BRPI0418183A - ensaios bioluminescentes e células úteis nos mesmos - Google Patents

ensaios bioluminescentes e células úteis nos mesmos

Info

Publication number
BRPI0418183A
BRPI0418183A BRPI0418183-2A BRPI0418183A BRPI0418183A BR PI0418183 A BRPI0418183 A BR PI0418183A BR PI0418183 A BRPI0418183 A BR PI0418183A BR PI0418183 A BRPI0418183 A BR PI0418183A
Authority
BR
Brazil
Prior art keywords
useful cells
bioluminescent assays
bioluminescent
assays
cells
Prior art date
Application number
BRPI0418183-2A
Other languages
English (en)
Inventor
Jiri Aubrecht
Jefferi John Osowski
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0418183A publication Critical patent/BRPI0418183A/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • C12N1/185Saccharomyces isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/85Saccharomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

"ENSAIOS BIOLUMINESCENTES E CéLULAS úTEIS NOS MESMOS". A presente invenção refere-se a novos ensaios bioluminescentes e a células e kits úteis nos mesmos.
BRPI0418183-2A 2003-12-24 2004-12-13 ensaios bioluminescentes e células úteis nos mesmos BRPI0418183A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53252803P 2003-12-24 2003-12-24
PCT/IB2004/004124 WO2005066628A1 (en) 2003-12-24 2004-12-13 Bioluminescent assays and cells useful therein

Publications (1)

Publication Number Publication Date
BRPI0418183A true BRPI0418183A (pt) 2007-04-27

Family

ID=34748806

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418183-2A BRPI0418183A (pt) 2003-12-24 2004-12-13 ensaios bioluminescentes e células úteis nos mesmos

Country Status (7)

Country Link
US (1) US20050148007A1 (pt)
EP (1) EP1706739A1 (pt)
JP (1) JP2007516716A (pt)
BR (1) BRPI0418183A (pt)
CA (1) CA2549532A1 (pt)
MX (1) MXPA06006440A (pt)
WO (1) WO2005066628A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008150802A1 (en) * 2007-05-29 2008-12-11 The Regents Of The University Of California Assays for mutagenesis detection
US9193983B2 (en) * 2007-05-29 2015-11-24 The Regents Of The University Of California Assays for mutagenesis detection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997757A (en) * 1987-12-23 1991-03-05 Genebiomed, Inc. Process for detecting potential carcinogens
JP3252921B2 (ja) * 1992-05-01 2002-02-04 キッコーマン株式会社 菌体数の測定方法

Also Published As

Publication number Publication date
EP1706739A1 (en) 2006-10-04
US20050148007A1 (en) 2005-07-07
MXPA06006440A (es) 2006-08-23
WO2005066628A1 (en) 2005-07-21
JP2007516716A (ja) 2007-06-28
CA2549532A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
BR0306589A (pt) Fotoproteìna com aperfeiçoada bioluminescência
DE10324396A8 (de) Brennstoffzelle
DE60226797D1 (de) Instrument zum Einbringen von Befestigungselementen für Transplantate
CY1108393T1 (el) Αναστολεις διπεπτιδυλ πεπτιδασης
BRPI0511008A (pt) agentes de ligação de il-13
NO20043486L (no) Transparent komposittsammensetning
DE60202932D1 (de) Klapptelefon mit abnehmbarem Display
TR199902655A2 (xx) K�k�rt-fonksiyonel poliorganosiloksanlar
DE60335716D1 (de) Beschleuniger-zusammensetzung
ECSP045255A (es) Cumarinas utiles como biomarcadores
DK1858921T3 (da) Fotoproteiner med forbedret bioluminescens og anvendelse af disse som intracellulære calciumindikatorer
MA29154B1 (fr) Promedicament amide de gemcitabine, compositions et utilisations associees
DE60329024D1 (de) Brennstoffzelle
DE60303345D1 (de) Brennstoffzelle
BRPI0415281A (pt) antagonistas de receptor de acetilcolina muscarìnico
EP1676133A4 (en) TESTS WITH PRIMARY CELLS
DE60323022D1 (de) Brennstoffzelle
BRPI0418183A (pt) ensaios bioluminescentes e células úteis nos mesmos
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
ITVR20050119A1 (it) Kit d'emergenza portatile
BRPI0517270A (pt) vidro de acrìlico com propriedades fotocrÈmicas
BR0316544A (pt) Compostos calcilìticos
DE502004000696D1 (de) Ausstellbare Flaplamelle
GB0202421D0 (en) Polyols in bioluminescence assays
DE50313182D1 (de) Kraftmesszelle

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.